meta-analysis | Q815382 |
review article | Q7318358 |
scholarly article | Q13442814 |
P2093 | author name string | Richard L Nelson | |
Jenna Morgan | |||
Kathryn Thomas | |||
Heather Lee-Robichaud | |||
P2860 | cites work | Comparison of a low dose polyethylene glycol electrolyte solution with lactulose for treatment of chronic constipation | Q24670446 |
PEG 3350 (Transipeg) versus lactulose in the treatment of childhood functional constipation: a double blind, randomised, controlled, multicentre trial | Q24685783 | ||
Functional bowel disorders | Q29620328 | ||
Constipation in early childhood: patient characteristics, treatment, and longterm follow up. | Q34378127 | ||
Efficacy and safety of traditional medical therapies for chronic constipation: systematic review | Q34556153 | ||
Constipation: evaluation and treatment | Q35176990 | ||
Epidemiology of constipation in North America: a systematic review | Q35748000 | ||
The health-related quality of life and economic burden of constipation | Q36128773 | ||
An extended assessment of bowel habits in a general population | Q36474156 | ||
Clinical epidemiology of chronic constipation. | Q38292260 | ||
Tolerance and efficacy of polyethylene glycol 3350/electrolyte solution versus lactulose in relieving opiate induced constipation: a double-blinded placebo-controlled trial | Q39450187 | ||
Chronic idiopathic constipation: pathophysiology and treatment | Q39466312 | ||
Irritable bowel syndrome: a technical review for practice guideline development | Q41493711 | ||
Bowel habits in young adults not seeking health care | Q43316417 | ||
Functional constipation and outlet delay: a population-based study. | Q43328740 | ||
Quality of life in patients with different types of functional constipation | Q43332483 | ||
Economic impact of low dose polyethylene glycol 3350 plus electrolytes compared with lactulose in the management of idiopathic constipation in the UK. | Q43871015 | ||
Comparison of polyethylene glycol 3350 and lactulose for treatment of chronic constipation in children | Q44012834 | ||
Prospective, randomized, parallel-group trial to evaluate the effects of lactulose and polyethylene glycol-4000 on colonic flora in chronic idiopathic constipation. | Q44841392 | ||
Effects of lactulose and polyethylene glycol on colonic transit | Q45250883 | ||
Abnormal colonic propagated activity in patients with slow transit constipation and constipation-predominant irritable bowel syndrome | Q47324753 | ||
Health-related quality of life in functional GI disorders: focus on constipation and resource utilization. | Q51953756 | ||
Pharmacoeconomic Impact of Low-Dose Macrogol 3350 plus Electrolytes Compared with Lactulose in the Management of Chronic Idiopathic Constipation among Ambulant Patients in Belgium. | Q64984380 | ||
Constipation: is there a new approach? | Q77870987 | ||
Chronic constipation | Q79107898 | ||
Impact of anal incontinence and chronic constipation on quality of life | Q79820257 | ||
Treatment of faecal impaction with polyethelene glycol plus electrolytes (PGE + E) followed by a double-blind comparison of PEG + E versus lactulose as maintenance therapy | Q79836144 | ||
An evidence-based approach to the management of chronic constipation in North America | Q80355694 | ||
Polyethylene glycol 4000 vs. lactulose for the treatment of neurogenic constipation in myelomeningocele children: a randomized-controlled clinical trial | Q83149183 | ||
P921 | main subject | β-lactulose | Q422689 |
constipation | Q178436 | ||
P577 | publication date | 2010-07-07 | |
P1433 | published in | Cochrane Database of Systematic Reviews | Q15750361 |
P1476 | title | Lactulose versus Polyethylene Glycol for Chronic Constipation |
Q37941498 | A practical approach to diagnosis and management of functional constipation in adults |
Q34319119 | American Gastroenterological Association technical review on constipation |
Q57483977 | Bowel Dysfunction in Spinal Cord Injury |
Q89733025 | Chronic Constipation in the Elderly Patient: Updates in Evaluation and Management |
Q87251674 | Chronic constipation |
Q92982347 | Clinical Features of Severely Constipated Children: Comparison of Infrequent Bowel Movement and Fecal Soiling Groups |
Q37893982 | Clinical practice : diagnosis and treatment of functional constipation |
Q36754155 | Clozapine-treated Patients Have Marked Gastrointestinal Hypomotility, the Probable Basis of Life-threatening Gastrointestinal Complications: A Cross Sectional Study |
Q33458740 | Cochrane Review: Osmotic and stimulant laxatives for the management of childhood constipation (Review). |
Q41115255 | Comparison Between the Cassia Fistula`s Emulsion With Polyethylene Glycol (PEG4000) in the Pediatric Functional Constipation: A Randomized Clinical Trial. |
Q35855681 | Comparison of a Chinese Herbal Medicine (CCH1) and Lactulose as First-Line Treatment of Constipation in Long-Term Care: A Randomized, Double-Blind, Double-Dummy, and Placebo-Controlled Trial |
Q28077823 | Comparison of the effectiveness of polyethylene glycol with and without electrolytes in constipation: a systematic review and network meta-analysis |
Q24633140 | Consensus statement AIGO/SICCR diagnosis and treatment of chronic constipation and obstructed defecation (part II: treatment) |
Q37909902 | Constipation in childhood |
Q35077094 | Constipation in older adults: stepwise approach to keep things moving |
Q38794996 | Diagnosis and management of chronic constipation in adults |
Q35221706 | Differences in taste between three polyethylene glycol preparations: a randomized double-blind study |
Q36154036 | Effect and safety of deep needling and shallow needling for functional constipation: a multicenter, randomized controlled trial |
Q53361876 | Effect of Descurainia sophia (L.) Webb ex Prantl on Adult Functional Constipation: A Prospective Pilot Study. |
Q93058528 | Effect of red sugar on functional constipation in children compared to figs syrup; a randomized controlled trial study |
Q47103351 | Efficacy and Safety of Combined Oral and Enema Therapy Using Polyethylene Glycol 3350-Electrolyte for Disimpaction in Pediatric Constipation |
Q34478128 | Efficacy and tolerability of peg-only laxative on faecal impaction and chronic constipation in children. A controlled double blind randomized study vs a standard peg-electrolyte laxative |
Q42154976 | Fecal impaction: a cause for concern? |
Q33465629 | Flixweed vs. Polyethylene Glycol in the Treatment of Childhood Functional Constipation: A Randomized Clinical Trial |
Q38126435 | Functional constipation in children: the pediatric surgeon's perspective |
Q26745952 | Guidelines for the Diagnosis and Treatment of Chronic Functional Constipation in Korea, 2015 Revised Edition |
Q35576885 | Hydrocortisone malabsorption due to polyethylene glycols (Macrogol 3350) in a girl with congenital adrenal insufficiency. |
Q24187123 | Interventions for preventing postpartum constipation |
Q24187521 | Interventions for preventing postpartum constipation |
Q24193478 | Interventions for treating postpartum constipation |
Q24202770 | Interventions for treating postpartum constipation |
Q37850707 | Intestinal obstruction syndromes in cystic fibrosis: meconium ileus, distal intestinal obstruction syndrome, and constipation |
Q31104772 | Is the pharmacological treatment of constipation in palliative care evidence based? : a systematic literature review |
Q92433081 | Lactulose versus polyethylene glycol for disimpaction therapy in constipated children, a randomized controlled study |
Q24187956 | Laxatives for the management of constipation in people receiving palliative care |
Q90464754 | Macrogol (polyethylene glycol) 4000 without electrolytes in the symptomatic treatment of chronic constipation: a profile of its use |
Q36621652 | Management of Functional Constipation in Children: Therapy in Practice |
Q39041935 | Management of chronic constipation in patients with diabetes mellitus |
Q55467298 | Management of constipation in patients with Parkinson's disease. |
Q57788665 | Microbiota stability in healthy individuals after single-dose lactulose challenge-A randomized controlled study |
Q38248065 | Opioid-induced bowel dysfunction: epidemiology, pathophysiology, diagnosis, and initial therapeutic approach |
Q24202082 | Osmotic and stimulant laxatives for the management of childhood constipation |
Q24234825 | Osmotic and stimulant laxatives for the management of childhood constipation |
Q26470417 | Osmotic and stimulant laxatives for the management of childhood constipation |
Q36351543 | Parkinson's Disease and Its Management: Part 5: Treatment of Nonmotor Complications |
Q37524279 | Pediatrician's knowledge on the approach of functional constipation |
Q24194825 | Pharmacological treatment for antipsychotic-related constipation |
Q39002818 | Pharmacological treatment for antipsychotic-related constipation. |
Q46057246 | Pharmacological treatment of constipation |
Q43365122 | Polyethylene Glycol 3350 With Electrolytes vs Polyethylene Glycol 4000 for Constipation: A Randomized, Controlled Trial |
Q90219514 | Polyethylene glycol 3350 plus electrolytes for chronic constipation: a 2-week, randomized, double-blind, placebo-controlled study with a 52-week open-label extension |
Q36817397 | Primary Care Management of Chronic Constipation in Asia: The ANMA Chronic Constipation Tool |
Q39230910 | Randomised clinical trial: macrogol/PEG 3350+electrolytes versus prucalopride in the treatment of chronic constipation -- a comparison in a controlled environment |
Q27687628 | Recurrent abdominal pain in childhood. |
Q34524615 | Systematic review of stimulant and nonstimulant laxatives for the treatment of functional constipation |
Q33607256 | The Movement Disorder Society Evidence-Based Medicine Review Update: Treatments for the non-motor symptoms of Parkinson's disease |
Q34544343 | The Porirua Protocol in the Treatment of Clozapine-Induced Gastrointestinal Hypomotility and Constipation: A Pre- and Post-Treatment Study |
Q89492627 | The advantage of polyethylene glycol electrolyte solution combined with lactulose in patients with long interval preparation-to-colonoscopy |
Q38873815 | Tolerance and Long-Term Efficacy of Polyethylene Glycol 4000 (Forlax®) Compared to Lactulose in Elderly Patients with Chronic Constipation |
Q24202190 | Transcutaneous electrical nerve stimulation (TENS) for treatment of constipation in children |
Q26471173 | Transcutaneous electrical stimulation (TES) for treatment of constipation in children |
Q36191459 | Transcutaneous electrical stimulation (TES) for treatment of constipation in children. |
Q33621273 | Understanding and treating refractory constipation |
Q36161635 | WITHDRAWN: Transcutaneous electrical stimulation (TES) for treatment of constipation in children. |
Q53478280 | [Irritable bowel syndrome with constipation and functional constipation in adults: Treatment (Part 2 of 2)]. |
Q85914226 | [Pelvic floor and anal incontinence. Conservative therapy] |
Search more.